NMSG12 - Thalidomid
Official title: A phase 3 study with randomization to Melphalan/Prednisone/Thalidomide versus Melphalan/Prednisone/Placebo to patients with previously untreated multiple myelomaTrial start year: 2001
Trial website
No website available
Design paper
No design paper published
![Result paper](http://ctu.dk/wp-content/uploads/2020/11/NSMG12_main2010_remade-01.png)
Result paper
2010
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
Download full paper